- The Fiscal
- What We're
- What You
The search found 23 results in 0.087 seconds.
Waiting to act raises the cost of stabilizing the debt.
The growing cost of prescription drugs presents a significant challenge to the quality and affordability of healthcare in the United States.
Despite higher healthcare spending per capita, the U.S. generally does not have better health outcomes.
Healthcare expenditures in the U.S. are much higher than those of other developed countries.
Although the United States spends more on healthcare than other developed countries, its health outcomes are generally no better.
United States per capita healthcare spending is nearly three times the average of other developed countries.
The latest Financial Times-Peterson Foundation US Economic Monitor, released on July 7, 2020, reveals timely data about Americans’ deep concerns about the health and economic effects of the coronavirus (COVID-19) pandemic.
The latest Financial Times-Peterson Foundation US Economic Monitor, released on June 4, 2020, reveals how the coronavirus pandemic continues to have significant financial and economic impacts across wide swaths of American society.
The latest Financial Times-Peterson Foundation US Economic Monitor reveals that the coronavirus pandemic is financially impacting the vast majority of Americans, and there is broad-based support for federal response measures.